PROMETHEUS BIOSCIENCES INC (RXDX)
US74349U1088 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -150.56M | -141.75M | -90.19M | -31.14M | -16.73M | |||
| Depreciation Amortization | 775.00K | 629.00K | 258.00K | 110.00K | 40.00K | |||
| Change In Working Capital | -4.21M | -1.18M | 12.82M | -1.33M | -330.00K | |||
| Interest Paid | N/A | 0.00 | 315.00K | 520.00K | 0.00 | |||
| Taxes Paid | N/A | 4.00K | 15.00K | 10.00K | 10.00K | |||
| Other non cash items | 20.59M | 19.05M | 13.62M | 4.34M | -3.17M | |||
| OPERATING CASH FLOW | -133.41M | -123.25M | -63.51M | -28.02M | -20.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.28M | -2.70M | -1.14M | -200.00K | -280.00K | |||
| Other Investing Activity | N/A | -401.08M | 0.00 | -860.00K | 8.21M | |||
| INVESTING CASH FLOW | -595.16M | -403.78M | -1.14M | -1.06M | 7.93M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -7.96M | 7.34M | 0.00 | |||
| Stock Issued/Repurchased | 650.80M | 595.09M | 292.91M | 74.02M | 9.83M | |||
| Other Financing Activity | -35.92M | -32.89M | -17.26M | -1.48M | -80.00K | |||
| FINANCING CASH FLOW | 614.88M | 562.20M | 267.69M | 79.89M | 9.76M | |||
| CHANGE IN CASH | -113.69M | 35.17M | 203.05M | 50.81M | -2.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -133.41M | -123.25M | -63.51M | -28.02M | -20.20M | |||
| Capital Expenditure | -2.28M | -2.70M | -1.14M | -200.00K | -280.00K | |||
| FREE CASH FLOW | -135.69M | -125.96M | -64.64M | -28.22M | -20.48M | |||
All data in USD